European Medicines Agency validates Oasmia Pharmaceutical AB’s application to add efficacy data to the approved Apealea
Pharmaceutical Investing European Medicines Agency Validates Marketing Authorization Application for Trogarzo
Pharmaceutical Investing European Medicines Agency Authorizes Deferral of Paediatric Investigation Plan for Trogarzo
Pharmaceutical Investing Immune Pharmaceuticals Receives Positive Opinion for Orphan Drug Designation in the European Union for Bertilimumab for the Treatment of Bullous Pemphigoid
Pharmaceutical Investing Tetraphase Pharmaceuticals Receives Positive CHMP Opinion for Xerava as a Treatment for Complicated Intra-Abdominal Infections
Pharmaceutical Investing European CHMP Adopts Positive Opinion for Yescarta (axicabtagene ciloleucel)
Pharmaceutical Investing Alexion Submits Application for Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria in the EU
